Multi-arm covariate-adaptive randomization

被引:5
作者
Hu, Feifang [1 ]
Ye, Xiaoqing [2 ]
Zhang, Li-Xin [3 ]
机构
[1] George Washington Univ, Dept Stat, Washington, DC 20052 USA
[2] Renmin Univ China, Inst Stat & Big Data, Beijing 100872, Peoples R China
[3] Zhejiang Univ, Sch Math Sci, Hangzhou 310058, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
multiple treatment; balancing covariate; clinical trial; marginal balance; Markov chain; Hu and Hu's general procedure; Pocock and Simon's procedure; stratified permuted block design; ASYMPTOTIC PROPERTIES; CLINICAL-TRIALS; ALLOCATION; THERAPY; DESIGNS;
D O I
10.1007/s11425-020-1954-y
中图分类号
O29 [应用数学];
学科分类号
070104 ;
摘要
Simultaneously investigating multiple treatments in a single study achieves considerable efficiency in contrast to the traditional two-arm trials. Balancing treatment allocation for influential covariates has become increasingly important in today's clinical trials. The multi-arm covariate-adaptive randomized clinical trial is one of the most powerful tools to incorporate covariate information and multiple treatments in a single study. Pocock and Simon's procedure has been extended to the multi-arm case. However, the theoretical properties of multi-arm covariate-adaptive randomization have remained largely elusive for decades. In this paper, we propose a general framework for multi-arm covariate-adaptive designs which also includes the two-arm case, and establish the corresponding theory under widely satisfied conditions. The theoretical results provide new insights about balance properties of covariate-adaptive randomization procedures and make foundations for most existing statistical inferences under two-arm covariate-adaptive randomization. Furthermore, these open a door to study the theoretical properties of statistical inferences for clinical trials based on multi-arm covariate-adaptive randomization procedures.
引用
收藏
页码:163 / 190
页数:28
相关论文
共 47 条
  • [1] Thymoquinone and curcumin combination protects cisplatin-induced kidney injury, nephrotoxicity by attenuating NFκB, KIM-1 and ameliorating Nrf2/HO-1 signalling
    Al Fayi, Majed
    Otifi, Hassan
    Alshyarba, Mishari
    Dera, Ayed A.
    Rajagopalan, Prasanna
    [J]. JOURNAL OF DRUG TARGETING, 2020, 28 (09) : 913 - 922
  • [2] Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE
    Alexander, Brian M.
    Ba, Sujuan
    Berger, Mitchel S.
    Berry, Donald A.
    Cavenee, Webster K.
    Chang, Susan M.
    Cloughesy, Timothy F.
    Jiang, Tao
    Khasraw, Mustafa
    Li, Wenbin
    Mittman, Robert
    Poste, George H.
    Wen, Patrick Y.
    Yung, W. K. Alfred
    Barker, Anna D.
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (04) : 737 - 743
  • [3] Clinical assessment incorporating a personal genome
    Ashley, Euan A.
    Butte, Atul J.
    Wheeler, Matthew T.
    Chen, Rong
    Klein, Teri E.
    Dewey, Frederick E.
    Dudley, Joel T.
    Ormond, Kelly E.
    Pavlovic, Aleksandra
    Morgan, Alexander A.
    Pushkarev, Dmitry
    Neff, Norma F.
    Hudgins, Louanne
    Gong, Li
    Hodges, Laura M.
    Berlin, Dorit S.
    Thorn, Caroline F.
    Sangkuhl, Katrin
    Hebert, Joan M.
    Woon, Mark
    Sagreiya, Hersh
    Whaley, Ryan
    Knowles, Joshua W.
    Chou, Michael F.
    Thakuria, Joseph V.
    Rosenbaum, Abraham M.
    Zaranek, Alexander Wait
    Church, George M.
    Greely, Henry T.
    Quake, Stephen R.
    Altman, Russ B.
    [J]. LANCET, 2010, 375 (9725) : 1525 - 1535
  • [4] An adaptive design for multi-arm clinical trials
    Bai, ZD
    Hu, FF
    Shen, L
    [J]. JOURNAL OF MULTIVARIATE ANALYSIS, 2002, 81 (01) : 1 - 18
  • [5] Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view
    Berton, A. M.
    Prencipe, N.
    Giordano, R.
    Ghigo, E.
    Grottoli, S.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (04) : 873 - 875
  • [6] ADAPTIVE ALLOCATION IN RANDOMIZED CONTROLLED TRIALS
    BIRKETT, NJ
    [J]. CONTROLLED CLINICAL TRIALS, 1985, 6 (02): : 146 - 155
  • [7] Brief Intervention for Patients With Problematic Drug Use Presenting in Emergency Departments A Randomized Clinical Trial
    Bogenschutz, Michael P.
    Donovan, Dennis M.
    Mandler, Raul N.
    Perl, Harold I.
    Forcehimes, Alyssa A.
    Crandall, Cameron
    Lindblad, Robert
    Oden, Neal L.
    Sharma, Gaurav
    Metsch, Lisa
    Lyons, Michael S.
    McCormack, Ryan
    Konstantopoulos, Wendy Macias
    Douaihy, Antoine
    [J]. JAMA INTERNAL MEDICINE, 2014, 174 (11) : 1736 - 1745
  • [8] Inference under covariate-adaptive randomization with multiple treatments
    Bugni, Federico A.
    Canay, Ivan A.
    Shaikh, Azeem M.
    [J]. QUANTITATIVE ECONOMICS, 2019, 10 (04) : 1747 - 1785
  • [9] Inference Under Covariate-Adaptive Randomization
    Bugni, Federico A.
    Canay, Ivan A.
    Shaikh, Azeem M.
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2018, 113 (524) : 1784 - 1796
  • [10] Quantifying the cost in power of ignoring continuous covariate imbalances in clinical trial randomization
    Ciolino, Jody
    Zhao, Wenle
    Martin, Renee'
    Palesch, Yuko
    [J]. CONTEMPORARY CLINICAL TRIALS, 2011, 32 (02) : 250 - 259